Advertisement
New Zealand markets closed
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NZD/USD

    0.5940
    -0.0009 (-0.15%)
     
  • NZD/EUR

    0.5555
    +0.0015 (+0.27%)
     
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • OIL

    83.89
    +0.32 (+0.38%)
     
  • GOLD

    2,349.10
    +6.60 (+0.28%)
     
  • NASDAQ

    17,718.46
    +287.96 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,238.53
    +152.73 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • NZD/JPY

    93.5850
    +1.0890 (+1.18%)
     

Goldman Sachs reiterates $2 price target on Bed Bath & Beyond stock

Yahoo Finance Live's Brian Sozzi discusses a Goldman Sachs analyst's decision to reiterate Bed Bath & Beyond stock to Sell.

Video transcript

BRIAN SOZZI: Before we head to break, I want to highlight another very bearish call on the struggling Bed Bath & Beyond out of Goldman Sachs. Analyst Kate McShane reiterated her sell rating and $2 price target on the stock, which assumes 67% downside from current levels. Says McShane, "We continue to believe Bed Bath & Beyond will have a hard time driving customers to its store, especially in the second half, given the amount of competition we expect in the home goods industry." I have more from McShane's note now on the Yahoo! Finance home page, so give it a read and give it a share.